Bristol-Myers Squibb Co said on Thursday its operating profit rose by around a third from a year ago because fourth-quarter results included some revenue from Celgene, which the U.S. drugmaker bought in a $74 billion deal that closed in late November. Bristol-Myers said on an operating basis it earned $1.22 a share on $7.95 billion of revenue in the quarter. The results included Celgene revenue beginning Nov. 20. …read more
Source:: Yahoo Finance
